Royce Micro-Cap Fund Manager Commentary
article 12-31-2021

Royce Micro-Cap Fund Manager Commentary

The Fund handedly outpaced both its primary and secondary benchmark—the Russell Microcap and Russell 2000 Indexes—during the calendar year.

TELL US
WHAT YOU
THINK

Fund Performance

Royce Micro-Cap Fund gained 31.0% in 2021, beating both the Russell Microcap Index (+19.3%), its primary benchmark, and the Russell 2000 (+14.8%) for the same period. The Fund also outperformed both indexes for the 3- and 5-year periods ended 12/31/21. In addition, the Fund outpaced the Russell 2000 for the 25- year and identical 30-year and since inception periods ended 12/31/21. We are very pleased to have celebrated the Fund’s 30th anniversary at the end of 2021.

What Worked… And What Didn’t

All 10 equity sectors in which the Fund held investments made positive contributions to performance for the calendar year. Information Technology, Industrials, and Financials made the most sizable positive impacts while Consumer Staples, Real Estate, and Communication Services made the smallest positive contributions. At the industry level, semiconductors & semiconductor equipment (Information Technology), specialty retail (Consumer Discretionary), and professional services (Industrials) contributed most in 2021 while auto components (Consumer Discretionary), electronic equipment, instruments & components (Information Technology), and electrical equipment (Industrials) were the largest detractors.

At the position level, the Fund gained most from Aehr Test Systems, a worldwide supplier of systems for testing and burning-in logic, memory, photonic, power devices, and SiC (silicon carbide) wafers. The company is beginning to see significant traction in applications such as electric vehicles, where the cost of semiconductor failure is extremely high. While we have trimmed shares given its significant price appreciation, we maintained a meaningful position at year-end as we believe we are at the early stages of adoption in many of the company’s key end markets. Aspen Aerogels was the Fund’s next top contributor. Aspen sells proprietary insulation materials to the energy market—which rebounded in 2021—and to developing markets, including electric vehicles. The company secured the necessary financing to double its production capacity over the next several years in 2021, allowing it to meet its growing demand. In addition, it has several exciting new product applications in the research and development phase that hold potential growth opportunities. We continue to hold a large position as we believe electric vehicles are a significant long-term growth opportunity. B. Riley Financial, a capital markets firm that boasts operations spanning from investment banking to retailer bankruptcy liquidations, was the third top contributing position in 2021 as it continued to benefit from market share gains in its brokerage business.


Want to know more about the Fund?

LATEST PORTFOLIO + PERFORMANCE INFO

 


Conversely, Motorsport Games, which develops gaming software, detracted most for the calendar year. Unfortunately, a NASCAR-themed game that was its first software release following its IPO, had technical glitches that resulted in lower-than-expected sales. We have been selling our position as we wait for more clarity as to whether this game’s failed launch has permanently damaged the company’s game development reputation. American Superconductor is an energy technologies company specializing in the design and manufacture of power systems and superconducting wire. As a smaller company dealing with state and local governments, utilities, and the U.S Navy, order flows and revenue generation tend to be unpredictable. After a strong year in 2020, new flows were less robust in 2021, resulting in the shares declining. We have been adding to our position as we view the company’s technology as vibrant and critical to improving electric grids and believe that as business opportunities gain scale, the company’s results will become less volatile. Profound Medical develops and commercializes technology for the treatment of localized prostate cancer and was impacted by limitations to sell its product given COVID restrictions in many hospitals.

The portfolio’s advantage over the Russell Microcap came primarily from stock selection in 2021, though sector allocation also helped. Our substantially lower exposure and stock picks in Health Care gave the Fund its biggest advantage, followed by savvy stock selection in Information Technology and Industrials. Conversely, ineffective stock picks and our lower exposure to Consumer Discretionary caused a drag on relative results for the calendar year while Financials and Real Estate detracted because of our lower weightings, though stock selection also hurt in the latter sector.


Top Contributors to Performance 20211 (%)

Aehr Test Systems2.41
Aspen Aerogels1.33
B. Riley Financial1.27
Transcat1.21
Citi Trends1.11

1 Includes dividends

Top Detractors from Performance 20212 (%)

Motorsport Games Cl. A-0.66
American Superconductor-0.48
Profound Medical-0.40
CIRCOR International-0.36
Stoneridge-0.33

2 Net of dividends

Current Positioning and Outlook

Micro-cap stocks began the year with very strong returns before struggling through the second half of 2021. This has created considerable long-term prospects in many sectors, such as in technology, where supply chain consolidation has allowed certain micro-cap names to secure greater market share in a growing, high-demand industry. We have added on the margin to companies involved in energy and banks, where we remain underweight. This former group is mostly on the services side, with some holdings categorized in Industrials. In addition, we believe the long-term prospects and current valuations for value micro-caps look especially attractive to us. We think there is pent-up demand for autos and other consumer areas. With the global economy looking sound—especially once supply chain issues are resolved and COVID becomes more manageable—we are optimistic about the current environment, in particular for disciplined stock pickers with a long-term investment horizon like ourselves.

Average Annual Total Returns Through (%)

Annual Operating Expenses: Label

1 Not annualized.

Important Performance and Disclosure Information

Important Performance and Expense Information

All performance information reflects past performance, is presented on a total return basis, reflects the reinvestment of distributions, and does not reflect the deduction of taxes that a shareholder would pay on fund distributions or the redemption of fund shares. Past performance is no guarantee of future results. Investment return and principal value of an investment will fluctuate, so that shares may be worth more or less than their original cost when redeemed. Shares redeemed within 30 days of purchase may be subject to a 1% redemption fee, payable to the Fund, which is not reflected in the performance shown above; if it were, performance would be lower. Current month-end performance may be higher or lower than performance quoted and may be obtained at www.royceinvest.com. Gross operating expenses reflect the Fund's total gross annual operating expenses for the Investment Class and include management fees and other expenses. Net operating expenses reflect contractual fee waivers and/or expense reimbursements. All expense information is reported as of the Fund's most current prospectus. Royce has contractually agreed, without right of termination, to waive fees and/or reimburse expenses to the extent necessary to maintain the Investment Class's net annual operating expenses (excluding brokerage commissions, taxes, interest, litigation expenses, acquired fund fees and expenses, and other expenses not borne in the ordinary course of business) at or below 1.24% through April 30, 2022.

Current month-end performance may be obtained at our Prices and Performance page.

Notes to Performance and Other Important Information

The thoughts expressed in this report concerning recent market movements and future prospects for small company stocks are solely the opinion of Royce at December 31, 2021, and, of course, historical market trends are not necessarily indicative of future market movements. Statements regarding the future prospects for particular securities held in the Funds’ portfolios and Royce’s investment intentions with respect to those securities reflect Royce’s opinions as of December 31, 2021 and are subject to change at any time without notice. There can be no assurance that securities mentioned in this report will be included in any Royce-managed portfolio in the future.


As of 12/31/21, the percentage of Fund assets was as follows: Aehr Test Systems was 1.0%, Aspen Aerogels was 0.9%, B. Riley Financial was 1.2%, Transcat was 1.1%, Citi Trends was 1.2%, Motorsport Games Cl. A was 0.1%, American Superconductor was 0.6%, Profound Medical was 0.6%, CIRCOR International was 0.8%, Stoneridge was 0.7%


Sector weightings are determined using the Global Industry Classification Standard (“GICS”). GICS was developed by, and is the exclusive property of, Standard & Poor’s Financial Services LLC (“S&P”) and MSCI Inc. (“MSCI”). GICS is the trademark of S&P and MSCI. “Global Industry Classification Standard (GICS)” and “GICS Direct” are service marks of S&P and MSCI.

All indexes referred to are unmanaged and capitalization weighted. Each index’s returns include net reinvested dividends and/or interest income. Russell Company (“Russell”) is the source and owner of the trademarks, service marks and copyrights related to the Russell Indexes. Russell® is a trademark of Frank Russell Company. Neither Russell nor its licensors accept any liability for any errors or omissions in the Russell Indexes and/or Russell ratings or underlying data and no party may rely on any Russell Indexes and/or Russell ratings and/or underlying data contained in this communication. No further distribution of Russell Data is permitted without Russell’s express written consent. Russell does not promote, sponsor or endorse the content of this communication. The Russell 2000 Index is an index of domestic small-cap stocks. It measures the performance of the 2,000 smallest publicly traded U.S. companies in the Russell 3000 Index. The Russell 2000 Value and Growth Indexes consist of the respective value and growth stocks within the Russell 2000 as determined by Russell Investments. The Russell Microcap Index includes 1,000 of the smallest securities in the Russell 2000 Index, along with the next smallest eligible securities as determined by Russell. The Russell 2500 is an unmanaged, capitalization-weighted index of the 2,500 smallest publicly traded U.S. companies in the Russell 3000 index. The returns for the Russell 2500-Financial Sector represent those of the financial services companies within the Russell 2500 index. Source: MSCI. MSCI makes no express or implied warranties or representations and shall have no liability whatsoever with respect to any MSCI data contained herein. The MSCI data may not be further redistributed or used as a basis for other indexes or any securities or financial products. This report is not approved, endorsed, reviewed or produced by MSCI. None of the MSCI data is intended to constitute investment advice or a recommendation to make (or refrain from making) any kind of investment decision and may not be relied on as such. The MSCI ACWI Small Cap Index is an unmanaged, capitalization-weighted index of global small-cap stocks.The MSCI ACWI ex USA Small Cap Index is an index of global small-cap stocks, excluding the United States.The performance of an index does not represent exactly any particular investment, as you cannot invest directly in an index. Returns for the market indexes used in this report were based on information supplied to Royce by Russell Investments. Royce has not independently verified the above described information.

This material contains forward-looking statements within the meaning of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), that involve risks and uncertainties, including, among others, statements as to:

-the Funds’ future operating results,

-the prospects of the Funds’ portfolio companies,

-the impact of investments that the Funds have made or may make, the dependence of the Funds’ future success on the general economy and its impact on the companies and industries in which the Funds invest, and

-the ability of the Funds’ portfolio companies to achieve their objectives.

This discussion uses words such as “anticipates,” “believes,” “expects,” “future,” “intends,” and similar expressions to identify forward-looking statements. Actual results may differ materially from those projected in the forward-looking statements for any reason.

The Royce Funds have based the forward-looking statements included in this commentary on information available to us on the date of the commentary, and we assume no obligation to update any such forward-looking statements. Although The Royce Funds undertake no obligation to revise or update any forward-looking statements, whether as a result of new information, future events, or otherwise, you are advised to consult any additional disclosures that we may make through future shareholder communications or reports.

This material is not authorized for distribution unless preceded or accompanied by a current prospectus. Please read the prospectus carefully before investing or sending money. Smaller-cap stocks may involve considerably more risk than larger-cap stocks. (Please see ""Primary Risks for Fund Investors"" in the prospectus.)

Share:

Subscribe:

Sign Up

Follow: